HDAC9 and neoplasm: Class II tumor suppressor genes are particularly interesting drug targets since reversing the block of their gene expression, e.g. by DNA methyltransferase (DNMT) inhibitors or histone deacetylase (HDAC) inhibitors could lead to tumor regression.